Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19.

Details

Ressource 1Request a copy Under indefinite embargo.
UNIL restricted access
State: Public
Version: Final published version
License: Not specified
Serval ID
serval:BIB_087C444907D1
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19.
Journal
Drug safety
Author(s)
Marzolini C., Stader F., Leuppi-Taegtmeyer A., Stoeckle M., Battegay M., Sendi P.
ISSN
1179-1942 (Electronic)
ISSN-L
0114-5916
Publication state
Published
Issued date
02/2021
Peer-reviewed
Oui
Volume
44
Number
2
Pages
255-257
Language
english
Notes
Publication types: Letter ; Comment
Publication Status: ppublish
Keywords
Drug-Related Side Effects and Adverse Reactions, Female, Humans, Long QT Syndrome/chemically induced, Long QT Syndrome/diagnosis, Lopinavir/adverse effects, Male, Pharmaceutical Preparations, SARS-CoV-2, Sex Characteristics, COVID-19 Drug Treatment
URN
urn:nbn:ch:serval-BIB_087C444907D14
OAI-PMH
oai:serval.unil.ch:BIB_087C444907D1
DOI
10.1007/s40264-020-01025-z
Pubmed
33245507
Web of science
000593379200001
Open Access
Yes
Create date
25/08/2023 5:17
Last modification date
06/08/2024 6:02
Usage data